{
    "code": "02020335",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020335",
    "time": "2020-02-25 12:26:00",
    "許可證字號": "衛署藥輸字第020335號",
    "註銷狀態": "已註銷",
    "註銷日期": "86\/06\/30",
    "註銷理由": "移轉（申請商）",
    "製造許可登錄編號": "",
    "有效日期": "88\/02\/28",
    "發證日期": "83\/02\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202033500",
    "中文品名": "得甦幸注射劑",
    "英文品名": "DOXORUBICIN HYDROCHLORIDE INJECTION 2MG\/ML",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肺癌。",
    "劑型": "270注射劑",
    "包裝": "盒裝 小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DOXORUBICIN HCL",
    "限制項目": "02輸　入",
    "申請商名稱": "0929601100  美商康穗股份有限公司台灣分公司",
    "申請商地址": "台北巿民權東路三段６號１５樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0034000  PHARMACIA (PERTH) PTY LIMITED",
            "製造廠廠址": "15 BRODIE HALL DRIVE TECHNOLOGY PARK, BENTLEY WESTERN AUSTRALIA 6102",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "2",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ]
}